Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christopher Yee is active.

Publication


Featured researches published by Christopher Yee.


Bioorganic & Medicinal Chemistry Letters | 2009

Discovery of novel sphingosine kinase 1 inhibitors.

Yibin Xiang; Gary Asmussen; Michael Booker; Bradford Hirth; John L. Kane; Junkai Liao; Kevin D. Noson; Christopher Yee

Sphingosine kinase 1 (SK1) is an important enzyme that regulates the balance between ceramide and sphingosine-1-phosphate (S1P). Potent and novel SK1 inhibitors (6ag, 9ab and 12aa) have been discovered through a series of modifications of sphingosine (1), the substrate of this enzyme.


Bioorganic & Medicinal Chemistry Letters | 2010

Discovery of novel sphingosine kinase-1 inhibitors. Part 2 *

Yibin Xiang; Bradford Hirth; John L. Kane; Junkai Liao; Kevin D. Noson; Christopher Yee; Gary Asmussen; Maria Fitzgerald; Christine Klaus; Michael Booker

Building on our initial work, we have identified additional novel inhibitors of sphingosine kinase-1 (SK1). These new analogs address the shortcomings found in our previously reported compounds. Inhibitors 51 and 54 demonstrated oral bioavailability in a rat PK study.


Bioorganic & Medicinal Chemistry | 1994

Enzymes for the resolution of α-tertiary-substituted carboxylic acid esters

Helmut Kallwass; Christopher Yee; Todd Blythe; Thomas J. McNabb; Elizabeth Rogers; Spencer Shames

Abstract Aromatic α-amino-α-methyl acids and α-hydrazino-α-methyl acids are known aromatic amino acid decarboxylase inhibitors. Specific derivatives such as 2-amino-2-methyl-3-(3,4-dihydroxyphenyl)propanoate, Aldomet®, and 2-hydrazino-2-methyl-3-(3,4-dihydroxypheny Lodosyn®, have been developed as therapeutic agents to treat hypertension and Parkinsons disease, respectively. We recently reported a method for the kinetic resolution of the racemic esters of such compounds using a crude preparation of a novel enzyme catalyst from the yeast Candida lipolytica (Yee, C.; Blythe, T. A.; McNabb, T. J.; Walts, A. E. J. Org. Chem. 1992, 57, 3525-3527). Here we report the purification and initial characterization of the active enzyme component, an enzyme given the name Candida lipolytica ester hydrolase (CLEH). CLEH was purified to > 95% homogeneity by chromatography on MatrexTM Blue B resin. The enzyme was found to be a glycoprotcin with Mr = 80,000–300,000. In addition to esterolytic activity, the enzyme was found to catalyze the hydrolysis of amides, anilides and peptides. Sequence analysis of internal peptides of CLEH revealed striking homology to a number of enzymes belonging to the group of serine carboxypeptidases (E.G. 3.4.16.1). One peptide aligned with the canonical serine carboxypeptidase active site sequence, GESYAG. Based on the structural relationship of CLEH to serine carboxypeptidases, three representative serine carboxypeptidases were evaluated for their utility in resolving racemic α-tertiary ester substrates and compared with the activity of CLEH. All enzymes revealed similarly high activity and enantioselectivity towards the α-hydrazino-α-methyl ester precursor of the Parkinson-drug Carbidopa. However, differences in enantioselectivity were observed with other α-tertiary-substituted ester substrates. Serine carboxypeptidase-catalyzed ester resolutions thus offer a new route to many sterically hindered homochiral α-amino, α-hydrazino and α-hydroxy carboxylic acids.


Journal of Biological Chemistry | 2003

Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data.

Mack Kuo; Héctor R. Morbidoni; David Alland; Scott F. Sneddon; Brian B. Gourlie; Marina Leonard; Jill S. Gregory; Andrew Janjigian; Christopher Yee; James M. Musser; Barry N. Kreiswirth; Hiroyuki Iwamoto; Remo Perozzo; William R. Jacobs; James C. Sacchettini; David A. Fidock


Journal of Organic Chemistry | 1992

Biocatalytic resolution of tertiary .alpha.-substituted carboxylic acid esters: efficient preparation of a quaternary asymmetric carbon center

Christopher Yee; Todd Blythe; Thomas J. McNabb; Alan E. Walts


Archive | 2000

Inha inhibitors and methods of use thereof

Scott F. Sneddon; Christopher Yee; Andrew Janjigian


Archive | 2007

Novel small molecules with selective cytotoxicity against human microvascular endothelial cell proliferation

John L. Kane; Bradford Hirth; Christopher Yee; Hans-Peter Biemann; Marko J. Pregel


Archive | 2009

INHIBITORS OF SPHINGOSINE KINASE 1

Yibin Xiang; Bradford Hirth; John L. Kane; Junkai Liao; Kevin D. Noson; Christopher Yee


Archive | 1992

Enzymatic resolution of α-tertiary carboxylic acid esters

Helmut Kalwass; Christopher Yee; Todd Blythe; Spencer Shames; Elizabeth Rogers


Archive | 1991

Resolution of α-tertiary carboxylic acid esters using lipase from Candida lipolytica

Christopher Yee; Todd Blythe; Alan E. Walts

Collaboration


Dive into the Christopher Yee's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jill S. Gregory

University of Texas Southwestern Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge